产品编号
1300314
CAS 号
1162-56-7
中文名称
(8S,9S,10R,13S,14S,17S)-17-乙酰基-10,13-二甲基-8,9,10,11,12,13,14,15,16,17-十氢-1H-环戊二烯并[a]菲-3(2H)-酮(地屈孕酮杂质)
MDL 号
MFCD00199858
分子量
312.45
存储条件
网页展示纯度为入库指导纯度值,各批次间存在一定差异,实际纯度以收货为准
熔点
147-148 °C
沸点
462.8±45.0 °C at 760 mmHg
闪点
旋光
描述
TPSA
34.14
LogP
4.4995
H_Acceptors
2
H_Donors
0
Rotatable_Bonds
1
[1]. Agnieszka Rajtar-Ciosek, et al. Beneficial influence of postmenopausal estrogen therapy on serum adhesion molecules is independent of the route and dose of administration. Neuro Endocrinol Lett. 2011;32(3):340-4.
[2]. Daisuke Akashi, et al. Successful use of dydrogesterone as maintenance therapy in recurrent endometrial stromal sarcoma: a case report. Jpn J Clin Oncol. 2013 Nov;43(11):1145-9.
[3]. Ireneusz Po?a?, et al. Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration. Gynecol Endocrinol. 2013 Feb;29(2):165-8.
[4]. John C Stevenson, et al. Oral estradiol and dydrogesterone combination therapy in postmenopausal women: review of efficacy and safety. Maturitas. 2013 Sep;76(1):10-21.
[5]. Julia Maria Naumann, et al. Biotechnological production of 20-alpha-dihydrodydrogesterone at pilot scale. Appl Biochem Biotechnol. 2011 Sep;165(1):190-203.
警示图
警示词
Warning
危险申明
H302-H315-H319-H335
警告申明
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
GHS 编码
GHS07
展开更多
现货供应
专业护航
售后无忧
品质保障
无需凑单